Skip to main content

Table 4 Clinical applications of diode lasers in the selection of immotile but viable spermatozoa before ICSI

From: Applications of laser technology in the manipulation of human spermatozoa

Study

Source of spermatozoa

Type

Intensity of laser

duration of exposure

No. cycles of ART

No. oocytes fertilized/Total oocytes

No. pregnancies

No. live births

References

Aktan et al. (2004)

24 patients with complete asthenozoospermia (complete immotile spermatozoa) and 21 patients with either obstructive or nonobstructive azoospermia (testicular spermatozoa)

Fresh

120 µJ

1.2 ms

24 (ejaculate)

21 (testicular)

64.2% (NA)

45.4% (NA)

33.3%(8/24)

25.0%(5/20)

28.0%(7/25)

19.0%(4/21)

[80]

Gerber et al. (2008)

A patient with Primary cilia dyskinesia

Fresh

400 µJ

5 ms

1

57.1% (4/7)

1

NA

[83]

Nordhoff et al. (2013)

48 patients with testicular biopsy

Fresh

NA

6-7ms

58 TESE-ICSI cycles

65 control cycles

52.7% (292/554)

42.1% (216/617)

NA

NA

[85]

Chen et al. (2015)

Two patients with obstructive azoospermia and severe asthenospermia

Fresh

NA

2 ms

2

83.3%(10/12); 100%(6/6)

2

NA

[86]

Chen et al. (2017a)

A patient with nonobstructive azoospermia (testicular spermatozoa)

Frozen-thawed

200 µJ

2 ms

1

80% (4/5)

1

NA

[87]

Chen et al. (2017b)

7 patients with severe asthenozoospermia (complete immotile spermatozoa) and 25 patients with azoospermia (testicular spermatozoa)

Fresh and frozen-thawed

120 µJ

1.2 ms

NS

78.7% (37/47) (ejaculate)

80.3% (139/173)(testicular)

NA

NA

[88]

Ozkavukcu et al. (2018)

A patient with Kartagener’s syndrome

Fresh

NA

350 µs

1

45.5% (10/22)

1

1

[84]

Chen et al. (2021)

33 TESA-ICSI cycles/99 controls

Fresh and frozen-thawed

200 µJ

2 ms

33 (test group)

99 (control group)

78.2%(283/362)

80.5% (763/948)

61.2% (30/49)

47.5% (76/160)

69.7% (23/33)

60.6% (60/99)

[89]

  1. NA: not available; TESA: testicular aspiration; ICSI: intracytoplasmic sperm injection